[Vectarian international multicenter study (VIMS) in hypoxemic chronic bronchitis patients treated by the double-blind placebo method for 1 year. Follow-up of the monitoring of 490 patients].
D000368:Aged; D015765:Almitrine; D001991:Bronchitis / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D000860:Hypoxia / Q000188:drug therapy* / Q000209:etiology; D008173:Lung Diseases, Obstructive / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010100:Oxygen / Q000097:blood; D010879:Piperazines / Q000627:therapeutic use*
D010879:Piperazines; D015765:Almitrine; D010100:Oxygen
Etude multicentrique internationale Vectarion (VIMS) chez des patients bronchitiques chroniques hypoxémiques traités à double insu contre placebo pendant un an. Suivi du monitoring sur 490 patients.